Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Tessera Therapeutics is an innovative life sciences company focused on pioneering a new biotechnology called Gene Writing™, which aims to revolutionize genetic medicine. Tessera is developing technologies that allow for precise and efficient modifications to the genome, addressing genetic diseases that traditional gene therapy and editing methods cannot effectively treat.
Tessera Therapeutics Funding
Sign up to gain insights into Tessera Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Mar 08, 2022 | 400M | ||
| Series B | Jan 13, 2021 | 232M | ||
| Series A | Jan 13, 2021 | 5M | ||
| Series A | Sep 29, 2020 | 7M | ||
| Series A | Sep 30, 2019 | 14M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Tessera Therapeutics Management Team
Investors
Qatar Investment Authority (QIA)
March Capital
Cormorant Asset Management
Hanwha Venture Capital Corporation
Alaska Permanent Fund (APFC)
Abu Dhabi Investment Authority (ADIA)
Artis Ventures
Longevity Fund
SoftBank
Altitude Life Science Ventures
Flagship Pioneering
Tessera Therapeutics Valuations & Financials
View real-time NPM data on Tessera Therapeutics stock including daily Tessera Therapeutics stock price estimates, valuation history, and historical share price information. Access Tessera Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Tessera Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Tessera Therapeutics? Get in touch to learn more.
Similar Companies
like Tessera Therapeutics
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Somatus
Healthcare & Life Sciences
Integrated care for patients with or at risk of developing kidney disease.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Solugen
Climate & Sustainability
Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.
ArsenalBio
Healthcare & Life Sciences
Develops programmable cell therapies for cancer patients.
Inari Agriculture
Climate & Sustainability
Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.
FAQ
We have answers
Tessera Therapeutics stock does not trade on public stock exchanges. Tessera Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Tessera Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Tessera Therapeutics Stock does not trade on public stock exchanges. In order to sell Tessera Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Tessera Therapeutics price per share was $7.26 as of June 05, 2026. This Tessera Therapeutics share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Tessera Therapeutics share price today and the factors driving Tessera Therapeutics valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Tessera Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Tessera Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Tessera Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Tessera Therapeutics is a private company and has not had an IPO. There is currently no Tessera Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Tessera Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
